Cargando…
Treating hypoxemic COVID-19 “ARDS” patients with almitrine: The earlier the better?
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Société française d'anesthésie et de réanimation (Sfar). Published by Elsevier Masson SAS.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347339/ https://www.ncbi.nlm.nih.gov/pubmed/32653550 http://dx.doi.org/10.1016/j.accpm.2020.07.003 |
_version_ | 1783556572382756864 |
---|---|
author | Bendjelid, Karim Giraud, Raphael Von Düring, Stephan |
author_facet | Bendjelid, Karim Giraud, Raphael Von Düring, Stephan |
author_sort | Bendjelid, Karim |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7347339 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Société française d'anesthésie et de réanimation (Sfar). Published by Elsevier Masson SAS. |
record_format | MEDLINE/PubMed |
spelling | pubmed-73473392020-07-10 Treating hypoxemic COVID-19 “ARDS” patients with almitrine: The earlier the better? Bendjelid, Karim Giraud, Raphael Von Düring, Stephan Anaesth Crit Care Pain Med Article Société française d'anesthésie et de réanimation (Sfar). Published by Elsevier Masson SAS. 2020-08 2020-07-09 /pmc/articles/PMC7347339/ /pubmed/32653550 http://dx.doi.org/10.1016/j.accpm.2020.07.003 Text en © 2020 Société française d'anesthésie et de réanimation (Sfar). Published by Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Bendjelid, Karim Giraud, Raphael Von Düring, Stephan Treating hypoxemic COVID-19 “ARDS” patients with almitrine: The earlier the better? |
title | Treating hypoxemic COVID-19 “ARDS” patients with almitrine: The earlier the better? |
title_full | Treating hypoxemic COVID-19 “ARDS” patients with almitrine: The earlier the better? |
title_fullStr | Treating hypoxemic COVID-19 “ARDS” patients with almitrine: The earlier the better? |
title_full_unstemmed | Treating hypoxemic COVID-19 “ARDS” patients with almitrine: The earlier the better? |
title_short | Treating hypoxemic COVID-19 “ARDS” patients with almitrine: The earlier the better? |
title_sort | treating hypoxemic covid-19 “ards” patients with almitrine: the earlier the better? |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347339/ https://www.ncbi.nlm.nih.gov/pubmed/32653550 http://dx.doi.org/10.1016/j.accpm.2020.07.003 |
work_keys_str_mv | AT bendjelidkarim treatinghypoxemiccovid19ardspatientswithalmitrinetheearlierthebetter AT giraudraphael treatinghypoxemiccovid19ardspatientswithalmitrinetheearlierthebetter AT vonduringstephan treatinghypoxemiccovid19ardspatientswithalmitrinetheearlierthebetter |